Sunshine Biopharma SBFM
NASDAQ SBFM
$0.83 +0.04 (+5.51%)
As of: Sep 30, 2026 · 10:24 AM EDT

Sunshine Biopharma (SBFM) Total Non-Current Liabilities (2015 - 2026)

Updated

Sunshine Biopharma (SBFM) posted Total Non-Current Liabilities of $475,820 for Q2 2026, down 32.7% from $706,530 a year earlier and down 11.2% from the prior quarter.

Analysis

Sunshine Biopharma (SBFM) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Sunshine Biopharma's Total Non-Current Liabilities came in at $596,785, down 19.9% from FY2024.

  • Annual Total Non-Current Liabilities shows a four-year compound annual growth rate of -25.1% (FY2021 to FY2025).
  • In prior years, Sunshine Biopharma's Total Non-Current Liabilities was $744,724 in FY2024 (+26.7%), $587,764 in FY2023 (-14.2%), $685,264 in FY2022 (-63.9%) and $1.9 million in FY2021.
  • The Q2 2026 figure stands as the lowest quarterly Total Non-Current Liabilities since Q1 2019.
  • On a year-over-year basis, Total Non-Current Liabilities has declined in each of the last three quarters, with growth averaging 3.8% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2025, with growth of 38.1%; the weakest was Q4 2022, with a decline of 63.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $535,614 (Q1 2026), $596,785 (Q4 2025) and $636,708 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 105.99 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 106.45 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -967.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 5.92 Bn
10 Sunshine Biopharma 1.12 Mn -37.97 Mn 2.43 Mn 475,820.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 475,820.00
Mar 31, 2026 535,614.00
Dec 31, 2025 596,785.00
Sep 30, 2025 636,708.00
Jun 30, 2025 706,530.00
Mar 31, 2025 722,199.00
Dec 31, 2024 744,724.00
Sep 30, 2024 489,027.00
Jun 30, 2024 511,635.00
Mar 31, 2024 545,697.00
Dec 31, 2023 587,764.00
Sep 30, 2023 598,719.00
Jun 30, 2023 639,882.00
Mar 31, 2023 656,168.00
Dec 31, 2022 685,264.00
Dec 31, 2021 1.90 Mn
Mar 31, 2019 338,973.00
Dec 31, 2018 289,847.00
Dec 31, 2016 274,104.00
Dec 31, 2015 1.27 Mn
API Access

Sunshine Biopharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SBFM&period=max&api_key=YOUR_API_KEY